A Phase 4 interventional study of Lidocaine Infusion and Standard of Care (SOC) in Fracture Arm, Fracture Closed of Lower End of Forearm, Unspecified and Fracture Elbow, sponsored by Nemours Children's Clinic. Recruiting at 1 site in United States. Open to participants aged 3 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-06.
Sponsored by Nemours Children's Clinic · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Elbow Fractures with a site in United States — 7 open to participants now, 7 under way, none of them phase 3. Elbow Fractures · United States.
Among the 17 studies in Elbow Fractures with a site in United States, this one is the 6th largest by planned enrollment of the 14 interventional ones that give a count, is one of 4 that started in 2026, is one of 3 in phase 4, and was the 15th registered.
48 studies on the registry are indexed under Elbow Fractures; 14 are open to participants now.
Browse Elbow Fractures studies →7 of the 17 studies in Elbow Fractures with a site in United States are open now. Recruiting first, the newest first:
University of Oklahoma · Sites in United States
Ages 3–10 · Healthy volunteers
AdventHealth · Sites in United States, Spain
Ages 18+
Nemours Children's Clinic · Sites in United States
Ages up to 18 · Healthy volunteers
Joseph Janicki · Sites in United States
Ages 7–17
University of California, Los Angeles · Sites in United States
Ages 4–12
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 10 Elbow Fractures studies recruiting now, 2 (20%) set no upper age limit and 8 (80%) stop at 75 or younger; 8 take children under 18; 3 take healthy volunteers.
This study: 3 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 68 across 30 interventional studies indexed under Elbow Fractures.
Median enrollment 85 across the 14 interventional studies, 61 across the 3 observational. Of the 9 that completed or were terminated, 4 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 17 have an industry lead sponsor. The 10 most frequent:
Nemours Children's Clinic is the lead sponsor of 130 studies on the registry; 26 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.
Nemours Children's Clinic has 2 studies filed under Elbow Fractures — fewer than ten, so there is no comparison to draw.
2 of the studies in Elbow Fractures with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520851University of OklahomaEfficacy of the Buzzy System on Pain and Fear Reduction in Elbow Fracture Pin Removal | 2027-04 |
| NCT07212036Nemours Children's ClinicThe Utilization of Ultrasound to Diagnose Pediatric Elbow Fractures | 2027-09-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Elbow Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a prospective, randomized, double-blind clinical trial evaluating whether intraoperative intravenous lidocaine infusion (IVLI) reduces opioid requirements and improves postoperative pain control in children undergoing surgical fixation of upper extremity long bone fractures under general anesthesia. Ninety pediatric patients, ages 3-18 will be enrolled and randomized 1:1 to receive either IV lidocaine or placebo (normal saline) during surgery.
All participants will receive standardized anesthesia care and postoperative pain management. Opioid consumption and pain scores will be measured intraoperatively and throughout the postoperative recovery, with the primary outcome focused on total opioid use 60 minutes after arrival to the post-anesthesia care unit (PACU). Secondary outcomes include opioid use at additional time points, postoperative pain scores, PACU length of stay, rescue antiemetic use and the relationship between infusion duration and outcomes.
Patients will be closely monitored for signs of local anesthetic systemic toxicity and other adverse events. The goal of this study is to determine whether IV lidocaine is an effective opioid-sparing adjunct in pediatric orthopedic surgery and to support safer, multimodal analgesia strategies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Lidocaine Infusion
Other: Standard of Care (SOC)
Patients will be randomized to receive either lidocaine infusion or placebo intraoperatively. Perioperative opioid requirements will be compared between the two groups.
Standard of care
Total perioperative opioid consumption
Determine the effect of IVLI on intraoperative and postoperative opioid consumption in pediatric patients undergoing orthopedic surgery for long bone fractures of the upper extremity
Time frame: 60 minutes after patient arrival to post-anesthesia care unit (PACU)
Postoperative pain scores
The maximum postoperative pain scores in patients who received IVLI will be equivalent or less than patients who received placebo in PACU at 30, 60, and 90 minutes and the time when patient meets Phase 1 PACU discharge criteria.
Time frame: 30, 60, 90 minutes and the time when patient meets Phase 1 PACU discharge criteria.
Rescue Anti-Emetic Use
Assess the effect of IVLI on rescue anti-emetic use and Phase 1 PACU length of stay.
Time frame: Duration of Phase 1 PACU length of stay
Infusion and Surgical Length
Evaluate if the infusion time of IVLI impacts post-operative opioid consumption and post- operative pain scores. Hypothesis: Patients who receive IVLI for \> 2 hours will have lower post- operative opioid requirements and post-operative pain scores than patients who receive the infusion for \< 2 hours.
Time frame: 60 minutes after patient arrives in post-anesthesia care unit (PACU)
Plan to share: Undecided
Started Jun 2026 (actual). Primary completion is estimated for Dec 2028, 30 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lidocaine